跳至主要内容
临床试验/NCT01592227
NCT01592227已完成1 期

A Pharmacokinetic Study Investigating the Rate and Extent of Absorption of Paracetamol and an Adjuvant From Two Different Paracetamol Formulations.

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Bioequivalence as measured by AUC and Cmax in fasted and semi-fed states

研究概览

简要总结

A pharmacokinetic study investigating the rate and extent of absorption of paracetamol and an adjuvant from two different paracetamol formulations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male or female volunteers aged 18-55 years with a body mass index ranging from 19-28 kilograms per square meter who have given informed consent

排除标准

  • 未提供

研究组 & 干预措施

Marketed paracetamol

Active Comparator

Marketed paracetamol

干预措施: Marketed paracetamol (Drug)

Experimental paracetamol formulation

Experimental

Experimental formulations

干预措施: Experimental paracetamol formulation (Drug)

结局指标

主要结局

Bioequivalence as measured by AUC and Cmax in fasted and semi-fed states

时间窗: baseline to 10 hours post dose

次要结局

  • Speed of absorption in fasted and semi-fed states(baseline to 10 hours post dose)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study to Compare Two Paracetamol Formulations. | 临床试验